Effect Of Ezetimibe Coadministration With Simvastatin In A Middle Eastern Population: A Prospective, Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial (0653-151)

Status:
Completed

Trial end date:
2004-08-01

Target enrollment:

Participant gender:

The primary outcome was percentage reduction of LDL-C after 6 weeks of randomization.

Phase 4

Merck Sharp & Dohme Corp.

Ezetimibe
Simvastatin